Saxenda is a prescription medication approved by the U.S
Hence, EBV UTPase may alter the synaptic structure and function in ME/CFS, as well as dysregulate neuronal communication, influencing cognitive processes
Some wellness protocols combine DSIP with other peptides or supportive therapies
It is effective in reducing aggression, mood swings, and hyperactivity while often having fewer side effects than older antipsychotic drugs
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides